Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Doctor-Patient Communication About Colorectal Cancer Screening

Completed

Conditions: Colorectal Cancer Screening

Interventions: Behavioral: surveys

First Posted Date: 2012-02-17

Last Posted Date: 2020-01-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 76

Registration Number: NCT01534923

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States
🇺🇸
Hhc, Gun Hill and Tremont, Bronx, New York, United States

MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning

Not Applicable

Completed

Conditions: Brain Cancer

Interventions: Procedure: preoperative fMRI. DTI and DSI with tractography

First Posted Date: 2012-02-16

Last Posted Date: 2023-06-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 145

Registration Number: NCT01534104

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)

Terminated

Conditions: Breast Cancer
Tobacco Dependence

Interventions: Drug: placebo
Drug: varenicline

First Posted Date: 2012-02-14

Last Posted Date: 2015-12-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 7

Registration Number: NCT01532232

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer

Phase 2

Completed

Conditions: Esophageal Cancer
Gastric Cancer

Interventions: Drug: Afatinib and Paclitaxel

First Posted Date: 2012-02-01

Last Posted Date: 2023-11-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 42

Registration Number: NCT01522768

Locations: 🇺🇸
Memorial Sloan Kettering Rockville Centre, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

and more 6 locations

Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

Active, not recruiting

Conditions: Breast Cancer
Rare Cancer

Interventions: Behavioral: AIM materials and assessments

First Posted Date: 2012-01-25

Last Posted Date: 2025-02-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 252

Registration Number: NCT01517945

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma

Phase 2

Completed

Conditions: Hodgkin's Lymphoma

Interventions: Drug: Brentuximab Vedotin (SGN-35)

First Posted Date: 2012-01-11

Last Posted Date: 2025-01-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 66

Registration Number: NCT01508312

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center

Completed

Conditions: Hematopoietic Stem Cell Transplant

Interventions: Behavioral: questionnaire

First Posted Date: 2012-01-05

Last Posted Date: 2013-07-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 519

Registration Number: NCT01504152

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer

Phase 1

Completed

Conditions: Invasive Adenocarcinoma of the Breast
Breast Cancer

Interventions: Biological: Ipilimumab
Procedure: Cryoablation

First Posted Date: 2011-12-30

Last Posted Date: 2016-01-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 19

Registration Number: NCT01502592

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome

Not Applicable

Active, not recruiting

Conditions: Liver Cancer

Interventions: Other: CT guided percutaneous ablation

First Posted Date: 2011-12-19

Last Posted Date: 2025-04-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 150

Registration Number: NCT01494324

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Phase 2

Completed

Conditions: Sarcoma
Neuroblastoma

Interventions: Drug: Cyclophosphamide, Topotecan, and Bevacizumab

First Posted Date: 2011-12-15

Last Posted Date: 2019-10-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 9

Registration Number: NCT01492673

Locations: 🇨🇦
Alberta Children'S Hospital, Calgary, Alberta, Canada
🇺🇸
Phoenix Children'S Hospital, Phoenix, Arizona, United States
🇺🇸
University of Colorado Health Sciences Center and The Children's Hospital, Denver, Colorado, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy